MAVIRET
Identification of Maviret
| No description |
Google image searchProduct monograph
Active ingredients
pibrentasvir, 40 MG
glecaprevir, 100 MG
DIN: 02467550
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 13-SEP-2017
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AP — Antivirals for treatment of HCV infections (ATC, ATC/DDD)
- J05AP57 — GLECAPREVIR AND PIBRENTASVIR (ATC/DDD)
Reference brand drug: Maviret
